Cardlytics (NASDAQ: CDLX) has been upgraded by equity research analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating in a research report distributed to clients and investors on Wednesday, Benzinga reports. The brokerage currently has a price target of $ 150.00 on the share. Wells Fargo & CompanyThe target stock price suggests a potential rise of 27.11% from the current stock price.

A number of other research companies have also recently published reports on CDLX. Craig Hallum upgraded Cardlytics shares from a “hold” rating to a “buy” rating and set a price target of $ 145.00 for the company in a report released Tuesday. William Blair downgraded Cardlytics shares from an “outperformance” rating to a “market performance” rating in a Thursday, January 14th report. They noted that the move was an appraisal call. JPMorgan Chase & Co. raised its price target on Cardlytics shares from $ 110.00 to $ 130.00 and rated the company “neutral” in a Monday March 22 report. Truist raised its price target on Cardlytics shares from $ 90.00 to $ 150.00 in a report on Monday, March 1. To finish, Zacks investment research cut Cardlytics shares from a “hold” note to a “sell” note in a report on Wednesday, February 10. A stock research analyst rated the stock with a sell rating, three issued a hold rating, and three assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $ 129.67.

Cardlytics stock open for $ 118.01 Wednesday. The company has a debt to equity ratio of 1.14, a current ratio of 6.08, and a rapid ratio of 6.08. The company has a market cap of $ 3.75 billion, a price-to-earnings ratio of -70.24 and a beta of 2.63. Cardlytics has a one-year minimum of $ 38.00 and a one-year maximum of $ 161.47. The company’s fifty-day moving average price is $ 121.57 and its two hundred-day moving average price is $ 119.98.

Cardlytics (NASDAQ: CDLX) last released its results on Sunday, February 28. The company reported EPS of ($ 0.05) for the quarter, missing the Thomson Reuters consensus estimate of ($ 0.03) of ($ 0.02). The company posted revenue of $ 67.08 million for the quarter, compared to analysts’ estimates of $ 60.84 million. Cardlytics posted a negative return on equity of 31.98% and a negative net margin of 23.91%. The company’s quarterly revenue was down 3.2% from the same quarter last year. During the same period of the previous year, the company achieved earnings per share of $ 0.18. As a group, selling analysts expect Cardlytics to post earnings per share of -2.08 for the current year.

Similarly, director Scott D. Grimes sold 2,000 shares of the stock in a trade dated Friday, April 16. The shares were sold for an average price of $ 124.07, for a total value of $ 248,140.00. Following the closing of the sale, the director now owns 251,827 shares of the company, valued at $ 31,244,175.89. The transaction was disclosed in a filing with the SEC, accessible via this link. Additionally, CFO Andrew Christiansen sold 250 shares of the stock in a trade dated Wednesday, April 14. The shares were sold for an average price of $ 119.00, for a total transaction of $ 29,750.00. Following the closing of the sale, the CFO now owns 16,597 shares of the company, valued at approximately $ 1,975,043. Disclosure of this sale can be found here. In the last quarter, insiders sold 50,256 shares of the company valued at $ 6,522,254. 6.50% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently changed their positions in the company. CVA Family Office LLC purchased a new position in Cardlytics during the fourth quarter valued at approximately $ 71,000. Capstone Triton Financial Group LLC acquired a new position in Cardlytics during the fourth quarter for a value of approximately $ 124,000. Nisa Investment Advisors LLC increased its stake in Cardlytics by 10.1% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,090 shares of the company valued at $ 156,000 after purchasing an additional 100 shares during the period. Tudor Investment Corp Et Al purchased a new position in Cardlytics during the fourth quarter worth approximately $ 201,000. Finally, Walleye Trading LLC purchased a new position in Cardlytics during the fourth quarter valued at approximately $ 211,000. Hedge funds and other institutional investors hold 97.03% of the company’s shares.

About Cardlytics

Cardlytics, Inc operates an advertising platform within financial institutions digital channels that include online, mobile, email, and various real-time notifications in the US and UK. It offers the Cardlytics platform, a proprietary native banking advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.

See also: What are closed-end mutual funds?

This instant news alert was powered by storytelling technology and MarketBeat financial data to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured article: What is the asset-to-cash ratio?

7 terrific dividend-paying stocks to buy for a comfortable retirement

There are people who will say that on the day of implementation and forget it, the retirement accounts are over. But it’s a story we’ve heard before. The truth is, the formula for saving for a comfortable retirement, like the formula for losing weight, hasn’t really changed. Much depends on whether an individual has the discipline to carry it out.

Dividend stocks remain an essential part of a retirement portfolio. As retirement approaches, the ability to reinvest dividends results in a higher total return. And once people need to live off their portfolios, dividends provide a source of income without having to dip into their capital.

However, not all dividend paying stocks are the same and many investors are drawn to the attractiveness of a high yielding dividend stock. But what you’re really looking for are companies that have a habit of increasing their dividend. The ability to increase a dividend over time shows that the company has a business model that can hold up regardless of the performance of the economy as a whole.

In this special presentation, we’ll highlight seven stocks that individuals can buy today to capture a stable, recurring dividend.

See “7 Great Dividend Stocks to Buy for a Comfortable Retirement”.